NeueHealth, Inc.
NEUE
$6.40
-$0.12-1.84%
NYSE
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -11.75% | 11.97% | |||
| Total Other Revenue | 5.05% | -0.45% | |||
| Total Revenue | -0.13% | 3.07% | |||
| Cost of Revenue | 1.20% | 2.82% | |||
| Gross Profit | -4.96% | 4.00% | |||
| SG&A Expenses | 8.60% | -8.76% | |||
| Depreciation & Amortization | 2.80% | -11.92% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.12% | -0.64% | |||
| Operating Income | -46.71% | 33.04% | |||
| Income Before Tax | -85.89% | 41.15% | |||
| Income Tax Expenses | -124.06% | 1,593.58% | |||
| Earnings from Continuing Operations | -63.34% | 33.76% | |||
| Earnings from Discontinued Operations | 413.44% | 22.13% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 69.24% | -1,729.29% | |||
| Net Income | 95.26% | 2.07% | |||
| EBIT | -46.71% | 33.04% | |||
| EBITDA | -57.83% | 36.87% | |||
| EPS Basic | 77.22% | 1.63% | |||
| Normalized Basic EPS | 5.15% | -71.80% | |||
| EPS Diluted | 77.22% | 1.63% | |||
| Normalized Diluted EPS | 5.15% | -71.80% | |||
| Average Basic Shares Outstanding | -0.68% | 0.35% | |||
| Average Diluted Shares Outstanding | -0.68% | 0.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||